Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

  1. Sáez-Llorens, X.
  2. Norero, X.
  3. Mussi-Pinhata, M.M.
  4. Luciani, K.
  5. de la Cueva, I.S.
  6. Díez-Domingo, J.
  7. Lopez-Medina, E.
  8. Epalza, C.
  9. Brzostek, J.
  10. Szymański, H.
  11. Boucher, F.D.
  12. Cetin, B.S.
  13. De Leon, T.
  14. Dinleyici, E.C.
  15. Gabriel, M.ÁM.
  16. Ince, T.
  17. Macias-Parra, M.
  18. Langley, J.M.
  19. Martinón-Torres, F.
  20. Rämet, M.
  21. Kuchar, E.
  22. Pinto, J.
  23. Puthanakit, T.
  24. Baquero-Artigao, F.
  25. Gattinara, G.C.
  26. Arribas, J.M.M.
  27. Ramos Amador, J.T.
  28. Szenborn, L.
  29. Tapiero, B.
  30. Anderson, E.J.
  31. Campbell, J.D.
  32. Faust, S.N.
  33. Nikic, V.
  34. Zhou, Y.
  35. Pu, W.
  36. Friel, D.
  37. Dieussaert, I.
  38. Lopez, A.G.
  39. McPhee, R.
  40. Stoszek, S.K.
  41. Vanhoutte, N.
  42. Erakutsi egile guztiak +
Aldizkaria:
The Journal of infectious diseases

ISSN: 1537-6613

Argitalpen urtea: 2024

Alea: 229

Zenbakia: 1

Orrialdeak: 95-107

Mota: Artikulua

DOI: 10.1093/INFDIS/JIAD271 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus